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ABSTRACT:  
The study investigated the effect of marijuana smoking on some haematological parameters of smokers in 
comparison to non-smokers. Blood samples were collected from one hundred and eighty nine randomly selected 
male voluntary marijuana smokers (test) and one hundred non-smokers (control) resident in Yenagoa, Nigeria. 
All subjects were between 18-50 years. The haematological parameters analysed include haemoglobin 
concentration (Hb), packed cell volume (PCV), total white cell count (WBC), red blood cell count (RBC), 
differential white cell count, platelet count (PLT); using Sysmex SX-1000i automated haematology analyser; 
erythrocyte sedimentation rate (ESR), using Westergren method; prothrombin time (PT) and activated partial 
thromboplastin time (APTT) using method adopted from Dacie and Lewis, 1994. There was no significant 
difference in the PCV, Hb, Total WBC, RBC, PT, APTT, PLT, monocyte count, and basophil count between the 
test subjects and the controls (p>0.05).  But there was a significant decrease in neutrophil count in the test 
subjects when compared with the controls (p<0.05). Also, there was a significant increase in ESR, lymphocyte 
count and eosinophil count in the test subjects when compared with the controls (p<0.05). This study has shown 
that marijuana usage results in marked differences in some haematological parameters which may lead to 
inflammation, reduced immunity and ability to fight infections by the users.  
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INTRODUCTION:   
Marijuana is a green, brown or gray mixture of dried shredded leaves, stems, seeds and flowers of the female 
Cannabis sativa plant. It is the most widely used illicit drug globally (Compton, et al., 2005; Pyriyamvada, et al., 
2010). Its health and psychological effects are not well understood and remains the subject of much debate, with 
opinions on its risks polarized along the lines of proponents’ views on what its legal status should be. An 
unfortunate consequence of this polarization of opinion has been the absence of any consensus on what health 
information the medical profession should give to patients who are users or potential users. 
Marijuana contains over four hundred and twenty six (426) chemical entities and more than sixty (60) are of the 
cannabinoids class (Mahlberg, et al., 2001) that includes cannabidiol (CBD) cannabinol (CBN) and delta-9,-
tetrahydrocannabinol (THC) (Klein, et al., 1998). Cannabinoids have been studied extensively in recent years 
and have been found to have important function in many physiological and pathophysiological processes. 
Marijuana cannabinoids are considered to be immunomodulatory that have the ability to increase or decrease 
immune function (Klein, et al., 1998). Evidently, the major psychoactive compound in marijuana extracts is 
THC which produces a multiplicity of effects in humans (Adams and Martin, 1996; Cabral, et al., 1998). 
Marijuana has a THC content of 0.5-5.0% (Adams and Martin, 1996). Marijuana is mostly smoked because this 
is the easiest way to achieve the desired psychoactive effects (Hall, et al., 1994). The tar phase of marijuana 
smoke contains same carcinogenic compounds contained in tobacco smoke, including polycyclic hydrocarbons 
such as benz(a)pyrene which was  identified as a key factor promoting human lung cancer (Denissenko, et al., 
1996), nitrosamines, reactive aldehyde and 50% higher concentration of polycyclic hydrocarbons which has been 
shown to promote mutations in the p53 oncogene believed to play an important role in human cancer 
(Denissenko, et al., 1996). 
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The most beneficial use of marijuana is its antiemetic properties in patients who are receiving chemotherapy and 
its ability to reduce intraocular pressure in the treatment of glaucoma. It can be used for cancer patients, AIDS 
patients, and other chronic diseases to produce a sense of euphoria (Scully, 2007). Its effect on the user depends 
on its strength or potency which is related to the amount of delta-9-tetrahydrocannabinol (THC) it contains. It 
produces euphoria and relaxation, perceptual alterations, time distortion, intensification of ordinary sensory 
experiences, anxiety and panic reactions (Ranganathan, et al., 2006; Osborne, et al., 2008). Marijuana smoking 
increases heart rate by 20-50% (Hall, et al., 1994). Concerns have been raised about the potential for long-term 
marijuana consumption to increase risk for schizophrenia, bipolar disorders and major depression (Leweke and 
Koethe, 2008; Rubin and Parolaro, 2008). 
The discovery of cannabinoids receptors located throughout the brain and body, suggested that the use of 
marijuana affects the brain in the same manner as a naturally occurring brain chemical (Abadinsky, 2004). There 
are two types of cannabinoids receptors (CB1 and CB2) (Alexander et al., 2009; Brady, et al., 2009). The CB1 
receptor is found primarily in the brain, at the terminal of the central and peripheral neurons (Howell, et al., 
2002; Pertwee and Ross, 2002; Szabo and Schlicker, 2005). The CB2 receptor is most abundantly found on the 
cells of the immune system, including the spleen, thymus, tonsils, bone marrow, pancreas, splenic 
macrophages/monocytes, mast cells, and peripheral blood leukocytes (Bouaboula, 1993; Howlett, et al., 2002; 
Fride, 2004; Delisi and Lynn, 2008).     
The influence of marijuana on immune function has been examined extensively over the last 25years using 
experimental models involving  drug-abusing human subjects and experimental animals exposed to marijuana 
smoke or injected with cannabinoids and invitro models employing immune cell cultures treated with various 
cannabinoids. For the most part, invivo and invitro studies suggest that marijuana (THC) is an immune 
modulator and has immunosuppressive effects on T and B lymphocytes (Kaminsky, et al., 1996; Klein, et al., 
1991; Bhargava, 1996),  as well as natural killer (NK) cells (Kusher, et al., 1994; Klein, et al., 1998), 
macrophages (Baldwin, et al., 1997; Zheng, et al., 1996; McCoy, et al., 1995; McCoy, et al., 1999), and 
neutrophils (Murikinati, et al., 2010). THC may exert its immunosuppressive effects through disruption of there 
homeostatic mechanisms by inhibiting the ability of lymphocytes to produce type 1 cytokines and promoting 
type 2 cytokine production (Newton, et al., 1994). In addition to studies examining marijuana effects on immune 
cell, other reports have documented that these substances modulate host resistance to various infectious agents. 
These results are intriguing and demonstrate that cannabinoids can be immunomodulatory and enhance the 
disease process (Klein, et al., 1998). In addition to the haemodynamic effects, marijuana smoke is associated 
with an increase in carboxyhaemoglobin resulting in decreased oxygen carrying capacity (Hollister, 1986). 
Marijuana may increase factor v11 activity, however, there are mixed results in terms of the effects of smoked 
marijuana on platelet function (Heiden, et al., 1980). Thus taken together, smoking marijuana is associated with 
an increase in myocardial oxygen demand and a concomitant decrease in oxygen supply (Pearl and Choi, 1992).  
Presently, there is an increase in the use of marijuana by young able-bodied Nigerians, cutting across sex 
divisions. Reasons proffered include frustrations, on account of current and consistent difficult economic 
situation in the country. The paucity of information on the haematological status of marijuana users in this part 
of the country, the importance on blood constituents individually or collectively, to healthy living and the reality 
of the poor status of our country’s economy for some time to come, with the government not succeeding in 
alleviating the situation effectively all crystallize to form the basis of this study, which assessed the effect of 
marijuana usage on some haematological  parameters in smokers in order to elucidate possible deviations from 
the non-smokers. 
MATERIALS AND METHODS. 
This study was carried out in Yenagoa, Bayelsa state South-South Nigeria. Bayelsa state is located within 
Latitude 40 151 North and Latitude 50 and 231 South. It is also within longitude 50 221 West and 60 451 East. It is 
bounded by Delta State on the North, Rivers State on the East and the Atlantic Ocean on the Western and 
Southern parts. Information on age, socio-economic status, lifestyle pattern such as consumption of alcohol, 
smoking and taking of medicines including past and present illnesses, were obtained by questionnaires. They 
were drawn from low, middle and high socio economic classes and of different ethnic groups. 
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SELECTION CRITERIA FOR SUBJECTS 
Inclusion Criteria:  
Subjects were 18years and above 
Only subjects whose urine sample confirmed the presence of cannabinoids using ACRO BIOTECH diagnostics 
cannabis test strips were selected for this study. 
Exclusion criteria 
Subjects above 60years, those who refused consent, immunocompromised subjects, those who smoked both 
marijuana and cigarette and subjects with history of bleeding or clotting disorders were excluded from the study.   
 
STUDY DESIGN 
A completely randomized experimental design was used for this study. Evidence of marijuana smoking was 
confirmed at smoking joints where volunteers, certified by colleagues as smokers for at least two years were 
recruited. Informed consent was obtained from volunteers before commencement of the study. The study 
involved a “posttest only” randomised experiment. Control subjects were individuals who have never smoked 
marijuana or cigarette in their life time. Blood specimen of both marijuana smokers and non-smokers were 
collected randomly and analysed. 
 ETHICAL CONSIDERATION 
Permission was obtained from the ethics committees of the Federal Medical Centre Yenagoa and the Bayelsa 
state ministry of Health, Yenagoa.  
RESULTS 
Two hundred and eighty nine persons participated in this study, comprising one hundred and eighty nine 
apparently healthy marijuana smokers and one hundred non-smokers representing the control group. All the 
subjects were between 18-50 years.  
Table 4.1 is a comparison of the mean ± standard deviation haematological parameters between non-smokers 
(controls) and marijuana smokers (test subjects). There was no significant difference between the mean Total 
WBC, HB, PCV, RBC, PT, APTT, platelet count, Monocyte % and Basophil % of marijuana smokers and that 
of control subjects (P>0.05). 
There was a significant difference between the mean, ESR, Neutrophil %, Lymphocyte % and Eosinophil % of 
marijuana smokers and that of controls (P<0.05).  
Table 4.1: Comparison of Mean ± standard deviation Haematological Parameters between Control and Test 
Subjects. 
 KEY: (NS) = Non significant                 (S) = Significant 
Parameters Control Samples Test Samples P Value Inference 
Total WBC Count 
(x109/L) 
   8.6± 0.88  6.1 ± 0.94  > 0.05       (NS) 
Platelet (x109/L)    194±25.90  224 ±7.03  > 0.05        (NS) 
RBC (x 1012/L)    4.1 ± 0.42  5.7 ± 0.52  > 0.05        (NS) 
PCV (%)   37.69 ± 3.52  40.61 ± 3.94  > 0.05        (NS) 
Hb (g/dl)   12.43 ± 1.18  13.33 ± 1.25  > 0.05         (NS) 
PT (secs)   13.17 ± 0.82  12.61 ± 1.84  > 0.05         (NS) 
APTT (secs)   33.63 ± .61  33.64 ± 0.94  > 0.05         (NS) 
ESR (mm/h)   4.28 ± 1.82  13.88 ± 5.36  < 0.05          (S) 
Neutrophils (%)   66.09 ± .90  28.28 ± 2.53  < 0.05          (S) 
Lymphocytes (%)   28.22 ±5.93 54.57 ± 2.88  < 0.05          (S) 
Monocytes (%)   3.06 ± 1.02 5.88 ± 1.66  > 0.05          (NS) 
Eosinophils (%)   2.33 ± 0.85 10.59 ± 2.99  < 0.05          (S) 
Basophils (%)   0.30 ± 0.14 0.68 ± 0.20  > 0.05          (NS) 
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DISCUSSION 
This study has clearly demonstrated the effects of marijuana smoking on some haematological parameters of 
smokers and this cannot be overemphasized as there was a significant difference in some of the parameters 
between marijuana smokers at different marijuana years and that of the non-smokers. There is abundant evidence 
that haematological values vary considerably between this two study groups. These changes may be due to 
several factors. Reports from all over the world have been published on packed cell volume, haemoglobin 
concentration, red blood cell count, platelet count, total white cell count, differential white cell count, 
erythrocyte sedimentation rate, prothrombin time and activated partial thromboplastin time. So far, most of these 
findings involved the use of concentration of cannabinoids far in excess of those employed in social use of 
marijuana; hence it is necessary that similar data be made available so as to compare the parameters of those 
involved in the recreational use of marijuana. 
In this study, the mean haemoglobin concentration obtained in marijuana smokers (test group) was marginally 
higher than those obtained in non-smokers (control group), but not statistically significant (P>0.05). Also the 
mean packed cell volume obtained in the test group was marginally higher than those obtained in the control 
group, but not statistically significant (P>0.05). This finding is similar to that of Oseni, et al., (2006); Amna and 
Nabiala (2011) but contrary to the findings of El-shahat, (2011) who got higher haemoglobin concentration and 
packed cell volume in the control group. There are many mechanisms by which marijuana smoking may raise 
the Hb concentration and PCV. Smoking leads to an appreciable rise in concentration of carboxyhaemoglobin 
which does not function in oxygen transport; an erythropoietin-mediated increase in erythropoiesis therefore 
occurs. 
The red blood cell count obtained in the test group was also higher than those in the control group, but not 
statistically significant. This confirms the study by El-shahat, (2011) who obtained a higher red blood cell count 
in the test group. The non-significant difference in the haematological values between smokers and non-smokers 
of cannabis is in line with the report of Isager and Hagerup, (1971), who found no effect of pipe and cigar 
smoking on haematological values. It is also in agreement with Beacofield et al., (1973), that haemoglobin and 
PCV in the blood of ten native volunteers, who smoked cannabis containing 10 mg cannabinoid remained within 
the normal range. This result is further reinforced by the report of Beacofield et al., (1973) that there was no 
significant difference between smokers and non-smokers in chest x-ray, blood parameters and alveolar debris. 
The marginally higher value observed for PCV in marijuana smokers in this study, agrees with Isabell and 
Hagerup, (1971) on cigarette smokers where PCV was increased as a result of smoking. This was explained by 
the increase in carbon monoxide level in the blood of smokers which induced erythrocytosis (Tashkin et al., 
1972) which has been suggested to result in the intrathorasic airway obstruction or pulmonary insufficiency 
leading to ventilation/perfusion imbalance that results in functional hypoxia or hypoxaemia and arterial oxygen 
unsaturation; increasing the demand on bone marrow for RBC production observed as increased haemoglobin 
concentration  to increase the oxygen carrying capacity of the blood  (Rubin and Comitas, 1975). The authors 
added that the brief exposure to smoke from marijuana cigarettes stimulated the formation of reactive oxygen 
species (ROS) by 80% over control levels and lowered intracellular glutathione levels by 81%. Also, the smoke-
induced ROS generation was in a dose- and time-dependent manner, suggesting that most of the oxidative effects 
are produced by the gaseous phase and concluded that Delta9-THC present in the smoke is a potent source of 
cellular oxidative stress that could also contribute significantly to cell injury and dysfunction in the lungs of 
smokers.  Also, the findings of the work are in agreement with the research by Valk, et al., (1997), who reported 
that in vitro anandamide (at low micromolar concentrations) acted via cannabinoid CB2 receptors to synergize 
with colony-stimulating factors (CSFs), interleukin-3 and erythropoietin to stimulate haematopoiesis. 
The total white cell count obtained in this study was marginally higher in the non-smokers than in the marijuana 
smokers, but not statistically significant (P>0.05). The variations observed were all in line with the reports of 
Klein, et al., (2003);  Oseni, et al., 2006; El-shahat, (2011); but contrary to the finding by Amna and Nabiala 
(2011) who found no changes between smokers and non-smokers. The marginally lower value observed in total 
white cell count of smokers in this study, though within the normal range is in line with the report of Brent-
Moore (2005) that induced peripheral blood leukopoenia was caused by a single oral dose of 23-30 mg of 
cannabinoid per kg weight in rats. Possible complications arising from additional inflammatory agent, which 
might complicate the bronchitis experienced generally in smokers, could thus be implicated with reduced total 
leukocyte count. In the present study, reduction of the count of total white blood cells in marijuana smokers 
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confirm the disturbances in the immune system function and the immune response to the smoke inhalation. This 
also accounted for the increase ESR observed in this study. Also, the findings of this study is reinforced by the 
report by Klein, et al., (2003) who found that a control group smoking a single marijuana cigarette every day for 
a year had a white-blood-cell count that was 39 percent lower than normal, thus damaging the immune system 
and making the user more susceptible to infection and sickness. 
The significantly increased lymphocyte percent observed in this study agrees with the findings by Amna and 
Nabiala, (2011); El-shahat, (2011) but is contrary to the low lymphocyte count observed by Oseni, et al., (2006). 
On the other hand, the mean neutrophil count in the control group was significantly higher than that of the test 
group (P < 0.05). These confirm the findings by Oseni, et al., (2006); Amna and Nabiala, (2011); Murikanati, et 
al., (2010); El-shahat, (2011); that marijuana smoking results in a reduction in neutrophil count. The mechanism 
of liver damage by the marijuana smoke, involves crossing biological membranes by the excessively formed 
peroxynitrite which diffuse one to two cell diameters as was described by Denicola, et al., (1998). The latter 
diffusion allows significant interactions with lipids, DNA, and proteins causing more organs damage which may 
include, liver, gonads and pituitary glands (Hogg and Kalyanaraman, 1999 and Pryor and Squadrito, 1995). 
Sarafian, et al. (1999) showed that marijuana (MJ) smoking produces inflammation, edema, and cell injury in the 
tracheobronchial mucosa of smokers and may be a risk factor for lung cancer via oxidative stress mediated 
mechanism. Hepatic ischemia/reperfusion injury is a significant clinical problem involved in the liver failure 
associated with marijuana smoke which is mostly metabolized in the liver cells. Such injury is characterized by 
Kupffer cell activation and PMN cell infiltration and activation as well as inflammatory cytokine responses. The 
first step in the pathophysiology of this injury is the priming and recruitment of neutrophils into the liver 
vasculature upon reperfusion by inflammatory mediators. After recruitment of neutrophils into the liver 
vasculature, the second step comprises endothelial cell activation, which promotes the attachment and activation 
of inflammatory cells resulting in endothelial damage and liver dysfunction. Next, adherent inflammatory cells 
transmigrate through the damaged endothelium, attach to hepatocytes, and become fully activated to release 
oxidants, pro inflammatory cytokines, free radicals and large amounts of nitric oxide  and proteolytic enzymes, 
which in turn trigger intracellular oxidative stress and mitochondrial dysfunction in hepatocytes, eventually 
culminating in cell death (Pacher, et al., 2007). The results of the present study confirm the conclusion of 
Hézode, et al., (2005) who showed that daily cannabis smoking is significantly associated with fibrosis. The 
mechanism of the latter liver damage may involve activation of CB1 receptors as was shown by Tam, et al. 
(2011) who illustrated that such receptors is activated in various liver diseases and contributes to the underlying 
pathologies. Also, the reduction of the number of the neutrophils caused by cannabinoids was reported in 
previous studies by Murikinati, et al. (2010) who suggested that the activation of cannabinoid 2 receptor (CB2) 
reduced ischemic injury and this action involved the reduction of the number of neutrophils in the ischemic brain 
of experimental mice. Also phagocytosis impaired in animals exposed to acute marijuana smoke was due to a 
water soluble cytotoxin in the gas phase of fresh smoke possibly impairing glycolysis necessary for some of the 
cell energy for phagocytosis (Huber, et al., 1980). Daniel and Watson (1987) reported that phagocytic activity 
inhibition may be due to the effect of cannabis on bone marrow synthesis and maturation of neutrophil cells. 
Alcohol and Drug Education (2006) that marijuana use can weaken the immune system and interrupt maturation 
of white blood cells. Therefore, marijuana users may be more vulnerable to illness  
The occurrence of higher eosinophil count in smokers, while the values in all non-smokers studied were normal, 
can be explained by the observation of Brent-Moore et al. (2005) that cannabis plants are contaminated with a 
range of fungal spore organisms, which cause secondary eosinophilic pneumonia. According to Rubin and Faber 
(1998), apart from circulating in the blood, eosinophils are also found in tissues near points of external 
environmental contact and in inflammatory cellular infiltrates. They exhibit specialized function in certain 
disorders and are conspicuously active in their protection against foreign substances like smoke and 
cannabinoids. The eosinophilia manifestation in the marijuana smokers could be as a result of individual 
response since susceptibility is individual dependent. Such individual resistance could be on account of 
nutritional status as well as dose and chronicity effect.  
Also the findings of this study which showed a slight increase in platelet count in smokers is in agreement with 
the work of Erikssen, et al., (1994)   who observed a small but statistically highly significant increase in platelet 
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count in marijuana smokers. This study also showed a slightly decreased prothrombin time and activated partial 
thromboplastin time among marijuana smokers when compared with non-smokers. The decrease, though not 
statistically significant (p>0.05) was in agreement with the work of Coetzee, et al., (2007),  that Cannabis sativa 
and the cannabinoids, THC and CBN, display anticoagulant activity and may be useful in the treatment of 
diseases such as type 2 diabetes in which a hypercoagulable state exists. 
CONCLUSION: 
Some haematological characteristics of marijuana smokers differ significantly from non-smokers. The most 
likely consequences are easy predispositions of cannabis smokers to preventable infections, consequent upon the 
possibility of reduced humoral and cell mediated immune responses. The occurrence of significantly higher 
eosinophil counts in the test subjects suggests an inflammatory, allergic reaction consequent upon the 
precipitated eosinophilia conspicuous in these subjects. This also reflected in the increase in other inflammatory 
marker such as erythrocyte sedimentation rate as was observed in the study. In addition to recruiting and 
activating other cells of the immune system, neutrophils play a key role in the front-line defense against invading 
pathogens.  Neutrophils also release an assortment of proteins in three types of granules by a process called 
degranulation. The contents of these granules have antimicrobial properties, and help combat infection. 
Therefore, neutropenia makes an individual highly susceptible to infections. 
Furthermore, the slight decrease in prothrombin time in marijuana users is as a result of increased factor vii 
activity associated with heavy use of marijuana.  This study has shown that heavy marijuana usage results in 
marked differences in some haematological and immunological parameters which may lead to reduced immunity 
and ability to fight infections by the users. It is also being recommended that further studies be carried out to 
check the therapeutic use of marijuana in the treatment of diseases in which hypercoagulable states exist       
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